The newly published research reveals a surprising discovery about how the body keeps inflammation in check, and the finding arrives at a moment when chronic inflammation affects millions of people worldwide. The study shows that a small RNA molecule works like a hidden switch, and when this switch fails, inflammation surges and cancer risk rises. This insight opens the door to new ways of treating inflammatory diseases and preventing tumors.
Fast Facts
Discovery: Researchers found how the YTHDF2 protein controls a tiny RNA switch that prevents runaway inflammation.
Why It Matters: The study reveals a new pathway linked to autoimmune diseases, UV-related skin damage, and early tumor formation.
The researchers uncovered a system that uses a protein called YTHDF2 to control a self-RNA molecule named U6 snRNA. This RNA normally helps the cell process other RNAs, but the team found it can also trigger inflammation when it escapes into the wrong part of the cell. The new work explains what stops that from happening and why this control matters for human health.
To test this, scientists from the University of Chicago examined human and mouse cells exposed to UVB light, a common environmental stressor. They also analyzed genetically modified mice, advanced RNA sequencing, molecular binding tests, and imaging across several cell types. These tools helped them track how U6 snRNA moves inside cells, how YTHDF2 binds to it, and how this process affects inflammatory pathways. They showed that UVB light disables YTHDF2, which allows U6 snRNA to build up and activate a receptor called TLR3 in endosomes. This receptor normally detects viral RNA, but here it mistakenly reacts to the cell’s own RNA.
The discovery matters because inflammation drives many diseases, including cancer, autoimmune disorders, and skin damage caused by sunlight. When YTHDF2 fails, U6 snRNA activates TLR3 and triggers a chain reaction of inflammatory genes, including IL-6, TNF-α, and COX-2. The study suggests that protecting YTHDF2 or controlling U6 snRNA could reduce tissue damage after UV exposure and may even slow tumor formation. In mouse models, losing YTHDF2 in the skin made UV-triggered inflammation stronger and accelerated tumor development.
Experts note that this finding changes how we think about inflammation caused by stress instead of infection. It adds a new layer to the understanding of RNA modification, showing that chemical marks like m6A help the immune system tell self RNA from viral RNA. One researcher involved in the study explained that the body “uses its own RNA as a controlled signal,” and when that control is lost, disease risk increases. This also explains why YTHDF2 levels drop in some autoimmune conditions such as lupus and type 1 diabetes, as shown in the study’s dataset.
The new insight connects molecular biology to larger issues. Because inflammation plays a role in aging, cancer, environmental stress response, and even metabolic diseases, the ability to tune this RNA switch could lead to new treatments. This mechanism also parallels challenges in biotechnology, where the innate immune system reacts strongly to RNA therapeutics. Understanding how cells distinguish between helpful and harmful RNA could guide safer RNA-based vaccines and gene therapies.
The next steps include testing whether drugs can stabilize YTHDF2, block harmful U6-TLR3 interactions, or boost the m6A RNA marks that help cells filter signals correctly. Researchers also want to explore whether this mechanism affects inflammation in organs beyond the skin and whether it explains inflammation seen in chronic diseases. Early results hint that this pathway may be active in several tissues, but more work is needed.
This study’s takeaway is clear. The body uses a small, chemical mark on a tiny RNA molecule to keep inflammation under control. When this system breaks, inflammation rises and tumors form more easily. By revealing how this hidden switch works, scientists have opened a new path toward therapies that could calm inflammation and protect against cancer.
Story Source:
Materials provided by University of Chicago. Content may be edited for style and length.
Journal Reference:
Seungwon Yang, Yan-Hong Cui, Haixia Li, Jiangbo Wei, Gayoung Park, Ming Sun, Michelle Verghese, Emma Wilkinson, Teresa Nam, Linnea Louise Lungstrom, Xiaolong Cui, Tae Young Ryu, Jing Chen, Marc Bissonnette, Chuan He, Yu-Ying He. YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesis. Nature Communications, 2025.
DOI: 10.1038/s41467-025-64898-7